A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This is a 12 month non-interventional study with solifenacin succinate, evaluating the effect
of solifenacin on quality of life (QoL) of patients previously treated with antimuscarinics
(Males and Females with Overactive Bladder (OAB) symptoms withdrawing their treatment with
antimuscarinics because of safety and/or efficacy reasons) - measured by Perception of
Treatment Satisfaction (TS-VAS) and to evaluate the effect of solifenacin on quality of life
measured by Over Active Bladder-q Short Form (OAB-q SF), EuroQol Group scoring system
(EQ-5D-5L).